Results 201 to 210 of about 154,358 (318)

Atrial amyloidosis: mechanisms and clinical manifestations

open access: yesEuropean Journal of Heart Failure, Volume 24, Issue 11, Page 2019-2028, November 2022., 2022
Atrial amyloidosis: pathophysiology and clinical manifestations. Atrial amyloidosis can manifest as part of a systemic disorder (as in amyloid light‐chain [AL] or transthyretin [ATTR] amyloidosis), or be isolated (in the form due to atrial natriuretic type [ANP] accumulation); this last form is often associated with permanent or persistent atrial ...
Giuseppe Vergaro   +11 more
wiley   +1 more source

Early genetic screening and cardiac intervention in patients with cardiomyopathies in a multidisciplinary clinic

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Patients with cardiomyopathies are a heterogeneous group of patients who experience high morbidity and mortality. Early cardiac assessment and intervention with access to genetic counselling in a multidisciplinary Cardiomyopathy Clinic may improve outcomes and prevent progression to advanced heart failure.
Chandu Sadasivan   +12 more
wiley   +1 more source

Simulation of cardiac arrhythmias in human induced pluripotent stem cell-derived cardiomyocytes. [PDF]

open access: yesPLoS One
Bommer T   +11 more
europepmc   +1 more source

Overview of Cardiac Arrhythmias and Treatment Strategies. [PDF]

open access: yesPharmaceuticals (Basel), 2023
Kingma J, Simard C, Drolet B.
europepmc   +1 more source

Relaxin mimetic in pulmonary hypertension associated with left heart disease: Design and rationale of Re‐PHIRE

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Despite receiving guideline‐directed medical heart failure (HF) therapy, patients with pulmonary hypertension associated with left heart disease (PH‐LHD) experience higher mortality and hospitalization rates than the general HF population.
Marcin Ufnal   +17 more
wiley   +1 more source

Cardiac Arrhythmias

open access: yesJournal of the American College of Cardiology, 2008
openaire   +2 more sources

Home - About - Disclaimer - Privacy